These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8645280)

  • 1. The activity of plant-derived antiretroviral proteins MAP30 and GAP31 against herpes simplex virus in vitro.
    Bourinbaiar AS; Lee-Huang S
    Biochem Biophys Res Commun; 1996 Feb; 219(3):923-9. PubMed ID: 8645280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
    Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
    Bourinbaiar AS; Coleman CF
    Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiviral agents, MAP30 and GAP31, are not toxic to human spermatozoa and may be useful in preventing the sexual transmission of human immunodeficiency virus type 1.
    Schreiber CA; Wan L; Sun Y; Lu L; Krey LC; Lee-Huang S
    Fertil Steril; 1999 Oct; 72(4):686-90. PubMed ID: 10521111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of antiviral and antitumor proteins MAP30 and GAP31 in cucurbits using the plant virus vector ZYMV-AGII.
    Arazi T; Lee Huang P; Huang PL; Zhang L; Moshe Shiboleth Y; Gal-On A; Lee-Huang S
    Biochem Biophys Res Commun; 2002 Mar; 292(2):441-8. PubMed ID: 11906182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30.
    Lee-Huang S; Huang PL; Sun Y; Chen HC; Kung HF; Huang PL; Murphy WJ
    Anticancer Res; 2000; 20(2A):653-9. PubMed ID: 10810336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 (HIV-1) inhibition, DNA-binding, RNA-binding, and ribosome inactivation activities in the N-terminal segments of the plant anti-HIV protein GAP31.
    Lee-Huang S; Kung HF; Huang PL; Bourinbaiar AS; Morell JL; Brown JH; Huang PL; Tsai WP; Chen AY; Huang HI
    Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12208-12. PubMed ID: 7527556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic fragments of anti-HIV and anti-tumor proteins MAP30 and GAP31 are biologically active.
    Huang PL; Sun Y; Chen HC; Kung HF; Lee-Huang S
    Biochem Biophys Res Commun; 1999 Sep; 262(3):615-23. PubMed ID: 10471373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication.
    Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P
    Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon.
    Lee-Huang S; Huang PL; Chen HC; Huang PL; Bourinbaiar A; Huang HI; Kung HF
    Gene; 1995 Aug; 161(2):151-6. PubMed ID: 7665070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of Viracea against acyclovir susceptible and acyclovir resistant strains of herpes simplex virus.
    Thompson KD
    Antiviral Res; 1998 Jul; 39(1):55-61. PubMed ID: 9754950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of an antitumor and antivirus agent: chemical modification of α-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycol.
    Meng Y; Liu S; Li J; Meng Y; Zhao X
    Int J Nanomedicine; 2012; 7():3133-42. PubMed ID: 22802682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
    Schnitzler P; Schneider S; Stintzing FC; Carle R; Reichling J
    Phytomedicine; 2008 Dec; 15(12):1108-16. PubMed ID: 18691858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol.
    Sasaki K; Hayashi K; Matsuya Y; Sugimoto K; Lee JB; Kurosaki F; Hayashi T
    J Nat Med; 2016 Apr; 70(2):217-24. PubMed ID: 26763002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
    Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL
    Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
    Schuhmacher A; Reichling J; Schnitzler P
    Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Houttuynia cordata targets the beginning stage of herpes simplex virus infection.
    Hung PY; Ho BC; Lee SY; Chang SY; Kao CL; Lee SS; Lee CN
    PLoS One; 2015; 10(2):e0115475. PubMed ID: 25643242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro.
    Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P
    Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of non toxic doses of acyclovir on nitric oxide and cellular death responses in herpesvirus types 1 and 2 infected hep-2 cells.
    Baskin H; Yazici Z; Baskin Y; Olgun N; Ozkul A; Bahar IH
    New Microbiol; 2005 Jul; 28(3):205-13. PubMed ID: 16240692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
    Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
    Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.